← Evidence map

ArticleOncotarget2018

Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance.

Aysegül Kaymak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29983888